The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Open accessAbstract
Inheritance of a defect in a neuronal mechanism that regulates response to auditory stimuli was studied in nine families with multiple cases of schizophrenia. The defect, a decrease in the normal inhibition of the P50 auditory-evoked response to the second of paired stimuli, is associated with attentional disturbances in schizophrenia. Decreased P50 inhibition occurs not only in most schizophrenics, but also in many of their nonschizophrenic relatives, in a distribution consistent with inherited vulnerability for the illness. Neurobiological investigations in both humans and animal models indicated that decreased function of the α7-nicotinic cholinergic receptor could underlie the physiological defect. In the present study, a genome-wide linkage analysis, assuming autosomal dominant transmission, showed that the defect is linked [maximum logarithm of the odds (lod) score = 5.3 with zero recombination] to a dinucleotide polymorphism at chromosome 15q13-14, the site of the α7-nicotinic receptor. Despite many schizophrenics’ extremely heavy nicotine use, nicotinic receptors were not previously thought to be involved in schizophrenia. The linkage data thus provide unique new evidence that the α7-nicotinic receptor gene may be responsible for the inheritance of a pathophysiological aspect of the illness.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In families affected with multiple cases of schizophrenia, the deficit in P50 gating segregates as an autosomal dominant and is linked to the CHRNA7 gene complex, which forms the α7-nicotinic acetylcholine receptor (26).”
From Sensory Processing Dysfunction in the Personal Experience and Neuronal Machinery of Schizophrenia (2015) · cites this paper as [26]
Citations
Cites
Spitzer, R. L. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770300115013 · Cited by 6,946
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,686
Parametric and nonparametric linkage analysis: a unified multipoint approach.
Kruglyak, L., Daly, M. J., Daly, M. J., & Lander, E. S. (1996) · PubMed Central · Cited by 2,883
Self-citationStrategies for multilocus linkage analysis in humans.
Lathrop, M. G., Lalouel, J.-M., Julier, C., & Ott, J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3443 · Cited by 2,560
Progress in experimental personality research
Maher, W. B., & Maher, B. A. (1964) · Academic Press eBooks · Cited by 2,347
Schizotaxia, schizotypy, schizophrenia.
Meehl, P. E. (1962) · American Psychologist · doi:10.1037/h0041029 · Cited by 2,036
Analysis of Human Genetic Linkage.
Edwards, A. W. F., & Ott, J. (1992) · Biometrics · doi:10.2307/2532370 · Cited by 1,691
Gating and Habituation of the Startle Reflex in Schizophrenic Patients
Braff, D. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820030038005 · Cited by 1,027
Couturier, S., Bertrand, D., Matter, J., Hernandez, M., Bertrand, S., Millar, N. S., Valera, S., BARKAS, T., & Ballivet, M. (1990) · Neuron · doi:10.1016/0896-6273(90)90344-f · Cited by 941
Adler, L. E., Pachtman, E., Franks, R. D., Pecevich, M., Waldo, M. C., & Freedman, R. (1982) · PubMed · Cited by 896
Self-citation
Flagged first, then by citations
1 of the 63 references couldn’t be matched to a known paper.
Research works printed but not linked: 8
- J-M Lalouel Am J Hum Genet 37, 700–718 (1985).
- L E Adler, E Pachtman, R Franks, M Pecevich, M C Waldo, R Freedman Biol Psychiatry 17, 639–654 (1982).
- W R Goff, P D Williamson, C VanGilder, R Allison, T C Fisher Prog Clin Neurophysiol 7, 126–145 (1980).
- L Kruglyak, M J Daly, M P Reeve-Daly, E S Lander Am J Hum Genet 58, 1347–1363 (1996).
- L Kruglyak, E S Lander Am J Hum Genet 57, 519–527 (1995).
- M Melissari, G Giordano, P Crafa, M Martella, R Ricci Pathologica 87, 78–81 (1995).
- L K Casaubon, M Melanson, I Lopes-Cendes, C Marineau, E Andersmann, F Andersmann, J Weissenbach, C Prevost, J P Bouchard, J Matheiu, G A Rouleau Am J Hum Genet 58, 28–34 (1996).
- 10.1002/(SICI)1096-8628(19960409)67:2<154::AID-AJMG5>3.0.CO;2-S · DOI
Cited by
Sorted by citations
Items 801–900 of 1,000
Li, C.-H., Liao, H., & Chen, C. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.07.013 · Cited by 13
Maier, W., Schwab, S. G., & Rietschel, M. (2000) · Current Opinion in Psychiatry · doi:10.1097/00001504-200001000-00002 · Cited by 13
Genetik schizophrener Störungen Neuere Konzepte und Befunde
Maier, W., Lichtermann, D., Rietschel, M., Held, T., Falkai, P., Wagner, M., & Schwab, S. G. (1999) · Der Nervenarzt · Cited by 13
FLASH Syndrome: Tapping into the Root of Chronic Illness
Binder, M. R. (2020) · American Journal of Clinical and Experimental Medicine · doi:10.11648/j.ajcem.20200806.11 · Cited by 12
Copy Number Variants: A New Molecular Frontier in Clinical Psychiatry
Moreno‐De‐Luca, D., & Cubells, J. F. (2011) · Current Psychiatry Reports · doi:10.1007/s11920-011-0183-5 · Cited by 13
CHRFAM7A copy number and 2-bp deletion polymorphisms and antisaccade performance
Petrovsky, N., Schmechtig, A., Flomen, R. H., Kumari, V., Collier, D. A., MAKOFF, A. J., Wagner, M., & Ettinger, U. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009784 · Cited by 12
The Epidemiology of the Genetic Liability for Schizophrenia
Hallmayer, J. F. (2000) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/000486740003401s08 · Cited by 12
Gurpegui, M., Díaz, F. J., Ortega, J. M. M., & de León, J. (2004) · Adicciones · Cited by 12
Could cognitive vulnerability identify high‐risk subjects for schizophrenia?
Sarfati, Y., & Hardy-Baylé, M. C. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.b.10251 · Cited by 12
Effects of smoking during antipsychotic withdrawal in patients with chronic schizophrenia
Apud, J. A., Egan, M. F., & Wyatt, R. J. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00230-3 · Cited by 12
Cleverley, K., Lee, W. C., Mumford, P., Collins, T., Rickman, M., Cunningham, T. J., Cleak, J., Mianné, J., Szoke-Kovacs, Z., Stewart, M. E., et al. (2021) · Mammalian Genome · doi:10.1007/s00335-021-09864-6 · Cited by 11
The concept of FDG-PET endophenotype in Alzheimer’s disease
During, E., Osorio, R. S., Elahi, F. M., Mosconi, L., & de Leon, M. J. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0633-1 · Cited by 14
Modelos experimentais de esquizofrenia: uma revisão
Salgado, J. V., Hetem, L. A. B., & Sandner, G. (2006) · Brazilian Journal of Psychiatry · doi:10.1590/s1516-44462006000200012 · Cited by 11
Mokhtari, M., Narayanan, B., Hamm, J. P., Soh, P., Calhoun, V. D., Ruaño, G., Kocherla, M., Windemuth, A., Clementz, B. A., Tamminga, C. A., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv147 · Cited by 11
Küry, S., Rubie, C., Moisan, J., & St�ber, G. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0060-4 · Cited by 11
Tsuneki, H., Kobayashi, S., Takagi, K., Kagawa, S., Tsunoda, M., Murata, M., Matsuoka, T., Wada, T., Kurachi, M., Kimura, I., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.030866 · Cited by 11
Cholinergic mechanisms in schizophrenia: Current concepts
Raedler, T. J., & Tandon, R. (2006) · Current Psychosis & Therapeutics Reports · doi:10.1007/bf02629410 · Cited by 11
Primate-Accelerated Evolutionary Genes: Novel Routes to Drug Discovery in Psychiatric Disorders
Moalic, J., Strat, Y. L., Lepagnol-Bestel, A.-M., Ramoz, N., Loe-Mie, Y., Maussion, G., Gorwood, P. A. P. M., & Simonneau, M. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790936338 · Cited by 12
THE EFFECT OF IMMOBILIZATION STRESS ON SENSORY GATING IN MICE
Süer, C., Dolu, N., & Özesmi, Ç. (2003) · International Journal of Neuroscience · doi:10.1080/00207450490249400 · Cited by 11
Hippocampal Availability of the α7 Nicotinic Acetylcholine Receptor in Recent-Onset Psychosis
Wong, N. R., Rubin, L. H., Harrington, C. K., Jenkins, K. R., Shinehouse, L. K., Yoon, M., Kilgore, J. J., Soule, A. R., Lesniak, W. G., Rowe, S. P., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.27163 · Cited by 10
Kempsill, F. E. J., Covernton, P. J. O., Whiting, P. J., & Connolly, J. G. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00646-9 · Cited by 10
Alcohol preference: association with reduced striatal nicotinic receptors
Tizabi, Y. (2001) · Alcohol and Alcoholism · doi:10.1093/alcalc/36.4.318 · Cited by 10
The Neuronal Nicotinic Acetylcholine Receptor in Some Hereditary Epilepsies
Barrantes, F. J., Aztiria, E., Rauschemberger, M. B., & Vasconsuelo, A. (2000) · Neurochemical Research · doi:10.1023/a:1007594516465 · Cited by 10
Sane genetics for schizophrenia
Riley, B. P., & Williamson, R. (2000) · Nature Medicine · doi:10.1038/73085 · Cited by 10
Mirza, N. R., Misra, A., & Bright, J. L. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00658-0 · Cited by 10
Chapter 5. Mental Disorders and Disability: Time to Reevaluate the Relationship?
Lehman, A. F., Alexopoulos, G. S., Goldman, H. B., Jeste, D. V., & Üstün, B. (2002) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890427644.lg05 · Cited by 10
The smoking cessation drug varenicline improves deficient P20–N40 inhibition in DBA/2 mice
Wildeboer, K. M., & Stevens, K. E. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.07.001 · Cited by 9
Introducing the Term “Neuroregulator” in Psychiatry
Binder, M. R. (2019) · American Journal of Clinical and Experimental Medicine · doi:10.11648/j.ajcem.20190703.11 · Cited by 9
Binder, M. R. (2021) · American Journal of Clinical and Experimental Medicine · doi:10.11648/j.ajcem.20210904.15 · Cited by 9
Electrophysiology of Seizure Disorders May Hold Key to the Pathophysiology of Psychiatric Disorders
Binder, M. (2019) · American Journal of Clinical and Experimental Medicine · doi:10.11648/j.ajcem.20190705.11 · Cited by 8
Markers of vulnerability in schizophrenia.
Ladea, M., & Prelipceanu, D. (2009) · PubMed Central · Cited by 9
Onde P50 dans la schizophrénie
Houy, E., & Thibaut, F. (2007) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(07)48130-5 · Cited by 9
Effects of smoking on P50 waveform in schizophrenic patients.
Turan, T., Dolu, N., Özsoy, S., Kılıç, C., Beflirli, A., & Eşel, E. (2009) · Psychiatry and Clinical Psychopharmacology · Cited by 9
Rees, K. A., Halawa, A. A., Consuegra‐García, D., Golub, V. M., Clossen, B. L., Tan, A. M., Montgomery, K. S., Reddy, D. S., Griffith, W. H., & Winzer‐Serhan, U. H. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147024 · Cited by 9
Input dysfunction and beyond—an evaluation of CPT components
Straube, E. R., Bischoff, N., Nisch, C., Sauer, H., & Volz, H. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00360-7 · Cited by 9
Genetics of Psychiatric Disorders
Nürnberger, J. I., Berrettini, W. H., & Niculescu, A. B. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-252-6_29 · Cited by 9
Long-lasting changes in neural networks to compensate for altered nicotinic input
John, D., & Berg, D. K. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.020 · Cited by 9
Shared Chromosomal Susceptibility Regions Between Autism and Other Mental Disorders
Chagnon, Y. C. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)71017-5 · Cited by 9
At Issue: Assessment of Schizophrenia: Getting Closer to the Cause
Conklin, H. M., & Iacono, W. G. (2003) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a007015 · Cited by 9
Treating Tobacco Addiction in Schizophrenia: Where do we go From Here?
George, T. P., & Vessicchio, J. C. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00154.x · Cited by 9
Nürnberger, J. I. (2002) · Psychiatric Genetics · doi:10.1097/00041444-200209000-00001 · Cited by 9
Relationship between P50 suppression and the cortical silent period
Möller, B., Light, G. A., Fitzgerald, P. B., Snyder, J. S., Chen, R. E., & Daskalakis, Z. J. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3282ef6a29 · Cited by 9
Gershon, E. S., & Badner, J. A. (2001) · CNS Spectrums · doi:10.1017/s1092852900001073 · Cited by 9
Chan, R. C. K. (2011) · Chinese Science Bulletin · doi:10.1007/s11434-011-4715-5 · Cited by 8
Halawa, A. A., Rees, K. A., McCamy, K. M., & Winzer‐Serhan, U. H. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154879 · Cited by 9
Binder, M. R. (2021) · American Journal of Clinical and Experimental Medicine · doi:10.11648/j.ajcem.20210906.12 · Cited by 8
Smith, D., Fisher, D. J., Blier, P., Ilivitsky, V., & Knott, V. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.07.008 · Cited by 8
Neurocognitive Effects of Nicotine and Tobacco in Individuals with Schizophrenia
Weinberger, A. H., Creeden, C. L., Sacco, K. A., & George, T. P. (2007) · Journal of Dual Diagnosis · doi:10.1300/j374v03n03_06 · Cited by 8
Sung, H., Ji, F., Levy, D. L., Matthysse, S., & Mendell, N. R. (2008) · Computational Statistics & Data Analysis · doi:10.1016/j.csda.2008.08.030 · Cited by 8
Validating Endophenotypes for Schizophrenia Using Statistical Modeling of Twin Data
Hall, M., & Rijsdijk, F. V. (2008) · Clinical EEG and Neuroscience · doi:10.1177/155005940803900211 · Cited by 8
BRAFF, D. L., Freedman, R., Schork, N. J., & Gottesman, I. I. (2008) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.6.2.foc221 · Cited by 8
Self-citationNeuronal Hyperexcitability: Significance, Cause, and Diversity of Clinical Expression
Binder, M. R. (2021) · American Journal of Clinical and Experimental Medicine · doi:10.11648/j.ajcem.20210905.16 · Cited by 8
Cholinergic pathways and cognition in patients with schizophrenia: A pilot study
Rajji, T. K., Chow, T. W., Voineskos, A. N., Links, K. A., Miranda, D., Mamo, D. C., Ismail, Z., Pollock, B. G., & Mulsant, B. H. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.006 · Cited by 8
Genetics of schizophrenia and related disorders
Maier, W., Rietschel, M., Linz, M., & Falkai, P. (2002) · Steinkopff eBooks · doi:10.1007/978-3-642-57516-7_2 · Cited by 8
The Neurochemistry of Schizophrenia
Moghaddam, B., & Krystal, J. H. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch19 · Cited by 8
The Schizophrenia Spectrum Personality Disorders
O’Flynn, K., Gruzelier, J. H., Bergman, A. J., & Siever, L. J. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch7 · Cited by 8
The Neurobiology of Schizophrenia
Bobo, W. V., Rapoport, J. L., Abi‐Dargham, A., Fatemi, S. H., & Meltzer, H. Y. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch19 · Cited by 8
Filbey, F. M., Holcomb, J. A., Nair, T. R., Christensen, J. D., & Garver, D. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00107-8 · Cited by 7
Chang, H., Li, L., Peng, T., Li, M., Gao, L., & Xiao, X. (2016) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32502 · Cited by 7
Albiñana, E., Luengo, J. G., Baraibar, A. M., Muñoz, M.-D., Gandı́a, L., Solís, J. M., & Hernández-Guijo, J. M. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1939-5 · Cited by 7
Beinat, C., Banister, S. D., van Prehn, S., Doddareddy, M. R., Hibbs, D. E., Sako, M., Chebib, M., Tran, T. P., Al‐Muhtasib, N., Xiao, Y., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.02.052 · Cited by 7
Noradrenergic antagonism of the P13 and N40 components of the rat auditory evoked potential
Keedy, S., Marlow-O’Connor, M., Beenken, B., Dorflinger, J. M., Abel, M. S., & Erwin, R. J. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0608-8 · Cited by 7
Psychiatric genetics in South Africa: cutting a rough diamond
Wright, G., Niehaus, D. J. H., Koen, L., Drögemöller, B. I., & Warnich, L. (2011) · African Journal of Psychiatry · doi:10.4314/ajpsy.v14i5.2 · Cited by 8
Lexical decision as an endophenotype for reading comprehension: An exploration of an association
Naples, A. J., Katz, L., & Grigorenko, E. L. (2012) · Development and Psychopathology · doi:10.1017/s0954579412000752 · Cited by 7
Hukic, D. S., Frisén, L., Backlund, L., Lavebratt, C., Landén, M., Träskman‐Bendz, L., Edman, G., Schalling, M., & Ösby, U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067450 · Cited by 7
Chen, C., Chen, C.-Y., Chern, S., Wu, P.-S., Chen, S.-W., Wu, F.-T., Chen, L., & Wang, W. (2019) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2019.07.022 · Cited by 7
Dettling, M., Sander, T., Weber, M., & Steinlein, O. K. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000130559.93748.65 · Cited by 7
Genetics of schizophrenia: current strategies
Sivagnansundaram, S., Müller, D., Gubanov, A., Potkin, S. G., & Kennedy, J. L. (2003) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(03)00014-8 · Cited by 7
Holtmann, M. H., Becker, K., El‐Faddagh, M., & Schmidt, M. H. (2004) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917.32.2.117 · Cited by 7
Molecular and cellular genetics of fragile X syndrome
Kaufmann, W. E., & Reiss, A. L. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990205)88:1 · Cited by 88
Intermediate Phenotypes in Genetic Studies of Schizophrenia
Egan, M. F., Leboyer, M., & Weinberger, D. R. (2003) · Wiley eBooks · doi:10.1002/9780470987353.ch15 · Cited by 7
Behavioral and Molecular Genetics and Developmental Psychopathology
Rende, R., & Waldman, I. D. (2015) · Wiley eBooks · doi:10.1002/9780470939390.ch10 · Cited by 7
Involvement of Neuronal Nicotinic Receptors in Disease
Clementi, F., COURT, J. A., & Perry, E. A. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_25 · Cited by 7
Kullmann, F., de Groat, W., & Artim, D. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4928-9.00035-4 · Cited by 1
Mode of transmission of schizophrenia
Ponnudurai, R. N., & Jayakar, J. (2010) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2010.03.002 · Cited by 6
Abubaker, R., Alaerts, M., Allman, A.-A., Barnett, J. H., Belujon, P., Bittner, R. A., Burne, T. H. J., Cahn, W., Chance, S. A., Cherkerzian, S., et al. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.08.015 · Cited by 6
Yu, J. (2010) · The Open Behavioral Science Journal · doi:10.2174/1874230001004010009 · Cited by 6
Genetic Factors and Neurocognitive Traits
Bates, J. A., & Malhotra, A. K. (2002) · CNS Spectrums · doi:10.1017/s1092852900017697 · Cited by 6
Ünal, G., & Arıcıoğlu, F. (2017) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2017.1379716 · Cited by 6
Sivan, M., Phillips, M., Baguley, I. J., & Nott, M. T. (2019) · Oxford University Press eBooks · doi:10.1093/med/9780198785477.003.0007 · Cited by 6
Damiano, J. A., Mullen, S. A., Hildebrand, M. S., Bellows, S. T., Lawrence, K. M., Arsov, T., Dibbens, L. M., Major, H. J., Dahl, H. M., Mefford, H. C., et al. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.09.007 · Cited by 8
Depression and effects of antidepressant drugs on the stress systems
(2005) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(05)80059-8 · Cited by 6
Chapter 3 The lipid hypothesis of schizophrenia
Horrobin, D. F. (2002) · New comprehensive biochemistry · doi:10.1016/s0167-7306(02)35032-4 · Cited by 6
Salamone, F. N., & Zhou, M. (2020) · McGill Journal of Medicine · doi:10.26443/mjm.v5i2.573 · Cited by 6
Genetics of Psychiatric Disorders
Nürnberger, J. I., Berrettini, W., & Niculescu, A. B. (2016) · Springer eBooks · doi:10.1007/978-1-4939-2528-5_29 · Cited by 6
[Smoking and schizophrenia: where is the biological connection?].
Üneri, Ö. Ş., Tural, Ü., & Memik, N. Ç. (2006) · PubMed · Cited by 6
The long and winding road of schizophrenia research
Jablensky, A. V. (2005) · Epidemiology and Psychiatric Sciences · doi:10.1017/s1121189x00007910 · Cited by 6
D2 dopamine receptor polymorphism and brain regional glucose metabolism
Noble, E. P., Gottschalk, L. A., Fallon, J. H., Ritchie, T. L., & Wu, J. C. (1997) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19970418)74:2 · Cited by 165
de la Salle, S., Choueiry, J., McIntosh, J. F., Bowers, H., Ilivitsky, V., & Knott, V. (2022) · Psychopharmacology · doi:10.1007/s00213-022-06090-z · Cited by 5
McCamy, K. M., Rees, K. A., & Winzer‐Serhan, U. H. (2022) · Cytokine · doi:10.1016/j.cyto.2022.156005 · Cited by 5
Shan, H., Wang, N., Gao, X., Wang, Z., Yu, J., Zhangsun, D., Zhu, X., & Luo, S. (2024) · Marine Drugs · doi:10.3390/md22050200 · Cited by 5
Zhang, Q., Du, Y., Zhang, J., Xu, X., Xue, F., Guo, C., Huang, Y., Lukas, R. J., & Chang, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137588 · Cited by 5
Electrophysiological Deficits in Schizophrenia: Models and Mechanisms
von Reyn, C. R., Michael, E., Freedman, R., Valerie, M., Michael, J., Chinn, G. A., & Steven, J. (2011) · InTech eBooks · doi:10.5772/27511 · Cited by 5
Self-citationNeurophyisological and Neurocognitive Endophenotypes for Schizophrenia Genetics Research
Joo, Y. H. (2008) · Psychiatry Investigation · doi:10.4306/pi.2008.5.4.199 · Cited by 5
Ma, J., Fan, J., Bian, L., Zhang, C.-S., Li, X., Gu, N., Feng, G., Clair, D. S., & He, L. (2008) · Psychiatry Research · doi:10.1016/j.psychres.2007.07.002 · Cited by 5
Preclinical and Clinical Aspects of Nicotinic Acetylcholine Receptor Imaging
Brust, P., Deuther‐Conrad, W., Donat, C. K., Barthel, H., Riss, P. J., Paterson, L. M., Hoepping, A., Sabri, O., & Cumming, P. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_18 · Cited by 5
Leonard, S. S., & Benfante, R. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106783 · Cited by 5
Self-citationNeurophysiologic correlates of psychiatric disorders and potential applications in epilepsy
Halford, J. J. (2003) · Epilepsy & Behavior · doi:10.1016/s1525-5050(03)00148-3 · Cited by 5
The Systems Theory of Autistogenesis
Malone, J. P. (2012) · SAGE Open · doi:10.1177/2158244012444281 · Cited by 7
Neurodevelopmental liabilities of substance abuse
Palomo, T., Archer, T., Beninger, R. J., & Kostrzewa, R. M. (2002) · Neurotoxicity Research · doi:10.1080/1029842021000010857 · Cited by 5
Metadata
- Authors
- Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., Rosenthal, J., Waldo, M. C., Reimherr, F., Wender, P., Yaw, J., Young, D. A., Breese, C. R., Adams, C., Patterson, D., Adler, L. E., Kruglyak, L., Leonard, S., & Byerley, W.
- Affiliations
- Baylor College of Medicine (US)
- Departments of Psychiatry, Pharmacology, Biochemistry, and Preventive Medicine and Biophysics, University of Colorado School of Medicine, Denver Veterans Affairs Medical Center, and Eleanor Roosevelt Institute for Cancer Research, Denver, CO 80262; Department of Psychiatry, University of Utah School of Medicine, Salt Lake City, UT 84132; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030-3498; National Center for Human Genome Research/National Institutes of...
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 1997-01-21
- Volume
- 94
- Issue
- 2
- Pages
- 587-592
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC19557
- OpenAlex
- W2144671685
- Cited by
- 1,141
- References
- 63
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 11 · 2020: 16 · 2019: 15 · 2018: 6 · 2017: 14 · 2016: 19 · 2015: 46 · 2014: 25 · 2013: 28 · 2012: 39
- FWCI
- 62.17
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- National Institutes of Health (5k02mh001089-03, 1f32mh010168-01, DA09457)
- National Institute on Aging (T32AG000029)
- National Institute of Mental Health (MH-44212, P50MH044212, MH01089, MH-10168-F32)
- National Institute on Drug Abuse (R01DA009457)
- National Center for Research Resources (P41RR003655, M01RR000064)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- schizophrenia, alpha7 nicotinic acetylcholine receptor, genetic linkage, autosomal dominant inheritance, attention deficits, family-based genetic study, nicotine use
- MeSH terms
- Auditory Perception, Chromosomes, Human, Pair 15, Evoked Potentials, Female, Genes, Genetic Markers, Humans, Genetic Linkage, Male, Pedigree, Receptors, Nicotinic, Schizophrenia, Chromosomes, Artificial, Yeast
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review